Investing.com - Baxter (NYSE:BAX) reported third quarter earnings that beat analyst's expectations on Wednesday and revenue that fell short of forecasts.
The firm reported earnings per share of $0.8 on revenue of $2.77B. Analysts polled by Investing.com expected EPS of $0.74 on revenue of $2.78B. That compared to EPS of $0.64 on revenue of $2.71B in the same period a year earlier. The company had reported EPS of $0.77 on revenue of $2.84B in the previous quarter.
For the year, Baxter shares are down 3.03%, under-performing the S&P 500 which is up 1.63% year to date.
Baxter follows other major Healthcare sector earnings this month
On October 16, J&J (NYSE:JNJ) reported third quarter EPS of $2.05 on revenue of $20.35B, compared to forecasts of EPS of $2.03 on revenue of $20.05B.
Pfizer (NYSE:PFE) earnings beat analyst's expectations on Tuesday, with third quarter EPS of $0.78 on revenue of $13.3B. Investing.com analysts expected EPS of $0.75 on revenue of $13.55B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar